MoneyWorks4Me

Zydus Lifesciences informs about transcript of earnings call

23 May 2024 Evaluate

Pursuant to regulations 30 and 46(2) (oa) of the Listing Regulations, Zydus Lifesciences has informed that it attached the transcript of the Company’s Q4 FY24 post results earnings call held on May 17, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.10
Dr. Reddys Labs. 1235.60
Cipla 1324.30
Lupin 1942.70
Zydus Lifesciences 1120.00
View more..